JP2023549522A5 - - Google Patents
Info
- Publication number
- JP2023549522A5 JP2023549522A5 JP2023528582A JP2023528582A JP2023549522A5 JP 2023549522 A5 JP2023549522 A5 JP 2023549522A5 JP 2023528582 A JP2023528582 A JP 2023528582A JP 2023528582 A JP2023528582 A JP 2023528582A JP 2023549522 A5 JP2023549522 A5 JP 2023549522A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- pharmaceutically acceptable
- acceptable salt
- effective amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063112783P | 2020-11-12 | 2020-11-12 | |
| US63/112,783 | 2020-11-12 | ||
| PCT/US2021/059211 WO2022104116A1 (en) | 2020-11-12 | 2021-11-12 | Use of short chain fatty acids in cancer prevention |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023549522A JP2023549522A (ja) | 2023-11-27 |
| JP2023549522A5 true JP2023549522A5 (enExample) | 2024-12-06 |
Family
ID=81601740
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023528582A Pending JP2023549522A (ja) | 2020-11-12 | 2021-11-12 | がん予防における短鎖脂肪酸の使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240009155A1 (enExample) |
| EP (1) | EP4243803A4 (enExample) |
| JP (1) | JP2023549522A (enExample) |
| KR (1) | KR20230127990A (enExample) |
| CN (1) | CN116782949A (enExample) |
| AU (1) | AU2021380836A1 (enExample) |
| CA (1) | CA3198162A1 (enExample) |
| WO (1) | WO2022104116A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025137671A1 (en) | 2023-12-22 | 2025-06-26 | Temple University-Of The Commonwealth System Of Higher Education | Short chain fatty acid compounds and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20030020482A (ko) * | 2001-08-29 | 2003-03-10 | 대한민국(서울대학교) | 소디움부티레이트를 유효성분으로 하는 항암제 |
| US20100216754A1 (en) * | 2007-11-13 | 2010-08-26 | Meritage Pharma, Inc. | Compositions for the treatment of inflammation of the gastrointestinal tract |
| KR102735818B1 (ko) * | 2015-01-23 | 2024-11-28 | 템플 유니버시티-오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 | 암 예방에서 단쇄 지방산의 용도 |
| WO2018089861A1 (en) * | 2016-11-11 | 2018-05-17 | The Regents Of The University Of California | Methods and compositions for the treatment of cancer and metabolic diseases |
| WO2018140687A1 (en) * | 2017-01-27 | 2018-08-02 | Temple University-Of The Commonwealth System Of Higher Education | Use of short chain fatty acids for the treatment and prevention of diseases and disorders |
| AU2019358875B2 (en) * | 2018-10-09 | 2025-08-21 | Monash University | Combination therapy for treatment and prevention of autoimmune and inflammatory diseases |
-
2021
- 2021-11-12 CN CN202180090042.7A patent/CN116782949A/zh active Pending
- 2021-11-12 KR KR1020237019775A patent/KR20230127990A/ko active Pending
- 2021-11-12 JP JP2023528582A patent/JP2023549522A/ja active Pending
- 2021-11-12 CA CA3198162A patent/CA3198162A1/en active Pending
- 2021-11-12 EP EP21892910.7A patent/EP4243803A4/en active Pending
- 2021-11-12 AU AU2021380836A patent/AU2021380836A1/en active Pending
- 2021-11-12 US US18/252,222 patent/US20240009155A1/en active Pending
- 2021-11-12 WO PCT/US2021/059211 patent/WO2022104116A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN114641293A (zh) | 一种fgfr抑制剂的用途 | |
| Yu et al. | Berberrubine attenuates mucosal lesions and inflammation in dextran sodium sulfate-induced colitis in mice | |
| JP2019527714A5 (enExample) | ||
| WO2022134306A1 (zh) | 3-羟基丁酸或其衍生物或可产生该物质的细菌组合物在治疗放射性肠损伤上的应用 | |
| Dong et al. | Protective effects of osthole, a natural derivative of coumarin, against intestinal ischemia-reperfusion injury in mice | |
| CN103446169A (zh) | 一种三七皂苷r1的新用途 | |
| CN105147703B (zh) | 黄柏酮在制备防治溃疡性结肠炎的药物中的应用 | |
| CN115463201A (zh) | 一种具有预防肠道炎癌转化的中药组合物及其制备方法与应用 | |
| CN102697771A (zh) | 山姜素的一种新用途 | |
| CA2946158C (en) | Pharmaceutical composition with anti-inflammatory agents and production process | |
| CN102218065B (zh) | 苦豆碱在制药中的新应用 | |
| WO2021208280A1 (zh) | 五谷虫在制备预防和治疗乳腺增生药物中的应用 | |
| CN110123821A (zh) | 一种精氨酸双糖苷的药物用途 | |
| CN104435027A (zh) | 一种经皮给药具有治疗痛经效果的药物组合物及应用其制备的外用制剂及其制备方法 | |
| US11925634B2 (en) | Use of koumine in preparation of medicament for treatment of inflammatory bowel disease | |
| CN103877084B (zh) | 一种治疗肛周溃疡的外用药物 | |
| CN105147661B (zh) | 升麻素在制备防治溃疡性结肠炎的药物或食品中的应用 | |
| CN104411309B (zh) | 阿可拉定在制备用于治疗原发性肝癌的药物中的用途 | |
| CN106937956A (zh) | 人参皂苷c-k用于制备治疗溃疡性结肠炎药物 | |
| EP3595632A1 (en) | Composition for use in the treatment of endometriosis and symptoms associated with endometriosis | |
| CN105079012A (zh) | 天麻素在制备防治溃疡性结肠炎的药物或食品中的应用 | |
| JP2023549522A (ja) | がん予防における短鎖脂肪酸の使用 | |
| CN118593501B (zh) | 预防和治疗小肠黏膜屏障损伤的药物组合物及其应用 | |
| CN110585182A (zh) | 双硫仑在制备治疗和预防高血脂药物或动脉粥样硬化药物中的用途 | |
| CN105748427B (zh) | 一种托匹司他肠溶片及其制备方法 |